Integra LifeSciences Holdings Corp (IART)-Financial and Strategic SWOT Analysis Review

Integra LifeSciences Holdings Corp (IART)-Financial and Strategic SWOT Analysis Review


  • Products Id :- GDME717FSA
  • |
  • Pages: 62
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Integra LifeSciences Holdings Corp (IART)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Integra LifeSciences Holdings Corp (Integra) is a medical technology company. Integra's orthopedics products comprise specialty metal implants, dermal regeneration products, orthobiologic products, tissue-engineered wound dressings, and nerve and tendon repair products. The company's neurosurgery products consist of ultrasonic surgery systems, systems for measurement of various brain parameters, cranial stabilization and brain retraction systems, and others. Integra solutions find application in orthopedic extremity surgery, neurosurgery, and reconstructive and general surgery. Integra serves hospitals, outpatient surgery centers, physician, veterinarian and dental practices. The company markets its solutions through direct sales representatives and distributors. Integra is headquartered in Plainsboro, New Jersey, the US.

Integra LifeSciences Holdings Corp Key Recent Developments

Apr 26,2017: Integra LifeSciences Reports First Quarter 2017 Financial Results

Apr 04,2017: Integra LifeSciences Announces Expansion of Credit Facility to include new $700 million term loan

Feb 23,2017: Integra LifeSciences Reports Fourth Quarter and Full-Year 2016 Financial Results and Updates 2017 Full-Year Guidance

Dec 07,2016: Integra LifeSciences Announces Expansion and Extension of Credit Facility to $1.5 Billion

Dec 05,2016: Integra LifeSciences announces management changes

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Integra LifeSciences Holdings Corp-Key Facts 6

Integra LifeSciences Holdings Corp-Key Employees 7

Integra LifeSciences Holdings Corp-Key Employee Biographies 8

Integra LifeSciences Holdings Corp-Major Products and Services 9

Integra LifeSciences Holdings Corp-Medical Equipment Pipeline Products Data 12

Integra LifeSciences Holdings Corp Pipeline Products by Equipment Type 12

Integra LifeSciences Holdings Corp Pipeline Products by Development Stage 13

Integra LifeSciences Holdings Corp-History 15

Integra LifeSciences Holdings Corp-Company Statement 21

Integra LifeSciences Holdings Corp-Locations And Subsidiaries 23

Head Office 23

Other Locations & Subsidiaries 23

Section 2-Company Analysis 27

Integra LifeSciences Holdings Corp-Business Description 27

Business Description-Orthopedics and Tissue Technologies 27

Orthopedics and Tissue Technologies-Overview 27

Orthopedics and Tissue Technologies-Financials 27

Business Description-Specialty Surgical Solutions 27

Specialty Surgical Solutions-Overview 27

Specialty Surgical Solutions-Financials 28

Integra LifeSciences Holdings Corp-Corporate Strategy 29

Integra LifeSciences Holdings Corp-SWOT Analysis 30

SWOT Analysis-Overview 30

Integra LifeSciences Holdings Corp-Strengths 30

Integra LifeSciences Holdings Corp-Weaknesses 31

Integra LifeSciences Holdings Corp-Opportunities 32

Integra LifeSciences Holdings Corp-Threats 33

Integra LifeSciences Holdings Corp-Key Competitors 34

Section 3-Company Financial Ratios 35

Financial Ratios-Capital Market Ratios 35

Financial Ratios-Annual Ratios 36

Performance Chart 39

Financial Performance 39

Financial Ratios-Interim Ratios 40

Financial Ratios-Ratio Charts 41

Section 4-Company's Lifesciences Financial Deals and Alliances 42

Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 42

Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Type, 2011 to YTD 2017 43

Integra LifeSciences Holdings Corp, Recent Deals Summary 44

Section 5-Company's Recent Developments 45

Apr 04, 2017: Integra LifeSciences Announces Expansion of Credit Facility to include new $700 million term loan 45

Feb 23, 2017: Integra LifeSciences Reports Fourth Quarter and Full-Year 2016 Financial Results and Updates 2017 Full-Year Guidance 46

Dec 07, 2016: Integra LifeSciences Announces Expansion and Extension of Credit Facility to $1.5 Billion 48

Dec 05, 2016: Integra LifeSciences announces management changes 49

Dec 05, 2016: Integra LifeSciences Announces Key Executive Appointments 50

Oct 27, 2016: Integra LifeSciences Reports Third Quarter 2016 Financial Results 51

Jul 28, 2016: Integra LifeSciences Reports Second Quarter 2016 Financial Results 52

Jun 16, 2016: Integra LifeSciences to Hold First International Tissue Technologies Symposium on June 16-17, 2016 in Lisbon, Portugal 54

Apr 27, 2016: Integra LifeSciences Reports First Quarter 2016 Financial Results 55

Feb 25, 2016: Integra LifeSciences Reports Fourth Quarter and Full Year 2015 Financial Results and Issues 2016 Full Year Guidance 56

Section 6-Appendix 58

Methodology 58

Ratio Definitions 58

About GlobalData 62

Contact Us 62

Disclaimer 62

List of Figures

Integra LifeSciences Holdings Corp Pipeline Products by Equipment Type 12

Integra LifeSciences Holdings Corp Pipeline Products by Development Stage 13

Integra LifeSciences Holdings Corp, Performance Chart (2012-2016) 39

Integra LifeSciences Holdings Corp, Ratio Charts 41

Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 42

Integra LifeSciences Holdings Corp, Medical Equipment, Deals by Type, 2011 to YTD 2017 43

List of Tables

Integra LifeSciences Holdings Corp, Key Facts 6

Integra LifeSciences Holdings Corp, Key Employees 7

Integra LifeSciences Holdings Corp, Key Employee Biographies 8

Integra LifeSciences Holdings Corp, Major Products and Services 9

Integra LifeSciences Holdings Corp Pipeline Products by Equipment Type 12

Integra LifeSciences Holdings Corp Number of Pipeline Products by Development Stage 13

Integra LifeSciences Holdings Corp Pipeline Products Summary by Development Stage 14

Integra LifeSciences Holdings Corp, History 15

Integra LifeSciences Holdings Corp, Other Locations 23

Integra LifeSciences Holdings Corp, Subsidiaries 23

Integra LifeSciences Holdings Corp, Key Competitors 34

Integra LifeSciences Holdings Corp, Ratios based on current share price 35

Integra LifeSciences Holdings Corp, Annual Ratios 36

Integra LifeSciences Holdings Corp, Annual Ratios (Cont...1) 37

Integra LifeSciences Holdings Corp, Annual Ratios (Cont...2) 38

Integra LifeSciences Holdings Corp, Interim Ratios 40

Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 42

Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Type, 2011 to YTD 2017 43

Integra LifeSciences Holdings Corp, Recent Deals Summary 44

Currency Codes 58

Capital Market Ratios 58

Equity Ratios 59

Profitability Ratios 59

Cost Ratios 60

Liquidity Ratios 60

Leverage Ratios 61

Efficiency Ratios 61

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Zimmer Biomet Holdings Inc, Wright Medical Group NV, Stryker Corporation, Smith & Nephew Plc, MiMedx Group Inc, Medtronic Plc, Johnson & Johnson, C. R. Bard Inc, Becton Dickinson and Co, Acelity L.P. Inc.

select a license

Single User License
USD 125 INR 8131
Site License
USD 250 INR 16263
Corporate User License
USD 375 INR 24394

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com